GP-Act III Acquisition Corp. Form 8-K Summary
Business Context and Reporting Period
GP-Act III Acquisition Corp., a Cayman Islands special purpose acquisition company, filed this Form 8-K regarding the consummation of its initial public offering on May 13, 2024. The company’s securities trade on Nasdaq under the symbols GPATU, GPAT, and GPATW.
Transaction and Key Financial Metrics
- The company sold 28,750,000 units at $10.00 per unit, including 3,750,000 units issued pursuant to the underwriter’s over-allotment option.
- The IPO generated gross proceeds of $287.5 million.
- Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole public warrant is exercisable at $11.50 per share, subject to adjustment.
- The company separately sold 7,000,000 private placement warrants at $1.00 per warrant, generating stated gross proceeds of $7.0 million.
- The filing states that $287.5 million, described as proceeds from the IPO and private placement warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, with Continental Stock Transfer & Trust Company as trustee. The stated trust-account amount does not reconcile to the separately disclosed aggregate gross proceeds of $294.5 million and should be verified against the audited balance sheet.
- The filing provides no revenue, operating profit, net income, cash-flow, margin, debt, or liquidity metrics beyond the IPO and trust-account information.
Material Changes Versus the Prior Comparable Period
The filing reports the company’s IPO and related private placement. No prior-period operating or financial results are presented for comparison.
Guidance, Outlook, Risks, and Unusual Items
- The filing does not provide business-combination guidance, a target-company update, earnings outlook, or management forecast.
- Private placement warrants are not redeemable by the company, generally cannot be transferred until 30 days after the initial business combination, may be exercised on a cashless basis, and carry registration rights.
- The company filed an audited balance sheet as of May 13, 2024 as Exhibit 99.1.
Investor Verification Items
- Verify the audited balance sheet’s cash and trust-account balances, particularly the discrepancy between the $294.5 million of disclosed gross proceeds and the stated $287.5 million deposited in trust.
- Review the terms, dilution effects, and exercise conditions of the public and private placement warrants.
- Monitor the company’s deadline and terms for completing an initial business combination, including redemption rights and potential liquidation provisions.